Organogenesis (ORGO) - 2024 Q4 - Earnings Call Transcript

Organogenesis (ORGO) Q4 2024 Earnings Call February 27, 2025 05:00 PM ET Company Participants Gary Gillheeney - President, CEO, Chair of the BoardDavid Francisco - Chief Financial Officer Conference Call Participants Brooks O'Neil - Senior Research AnalystRoss Osborn - Director, Lead Research Analyst - MedTech and DiagnosticsRyan Zimmerman - Managing Director & Medical Technology Analyst Operator Welcome, ladies and gentlemen, to the Fourth Quarter and Fiscal Year twenty twenty four Earnings Conference Call ...